These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

351 related articles for article (PubMed ID: 19770540)

  • 1. Spectrum of mutations in sarcoglycan genes in the Mumbai region of western India: high prevalence of 525del T.
    Khadilkar SV; Singh RK; Hegde M; Urtizberea A; Love DR; Chong B
    Neurol India; 2009; 57(4):406-10. PubMed ID: 19770540
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Revised spectrum of mutations in sarcoglycanopathies.
    Trabelsi M; Kavian N; Daoud F; Commere V; Deburgrave N; Beugnet C; Llense S; Barbot JC; Vasson A; Kaplan JC; Leturcq F; Chelly J
    Eur J Hum Genet; 2008 Jul; 16(7):793-803. PubMed ID: 18285821
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A biochemical, genetic, and clinical survey of autosomal recessive limb girdle muscular dystrophies in Turkey.
    Dinçer P; Leturcq F; Richard I; Piccolo F; Yalnizoglu D; de Toma C; Akçören Z; Broux O; Deburgrave N; Brenguier L; Roudaut C; Urtizberea JA; Jung D; Tan E; Jeanpierre M; Campbell KP; Kaplan JC; Beckmann JS; Topaloglu H
    Ann Neurol; 1997 Aug; 42(2):222-9. PubMed ID: 9266733
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Specific assembly pathway of sarcoglycans is dependent on beta- and delta-sarcoglycan.
    Shi W; Chen Z; Schottenfeld J; Stahl RC; Kunkel LM; Chan YM
    Muscle Nerve; 2004 Mar; 29(3):409-19. PubMed ID: 14981741
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The first case of primary alpha-sarcoglycanopathy identified in Albania, in two siblings with homozygous alpha-sarcoglycan mutation.
    Babameto-Laku A; Tabaku M; Tashko V; Cikuli M; Mokini V
    Genet Couns; 2011; 22(4):377-83. PubMed ID: 22303798
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sarcolemmal alpha and gamma sarcoglycan protein deficiencies in Turkish siblings with a novel missense mutation in the alpha sarcoglycan gene.
    Diniz G; Tosun Yildirim H; Akinci G; Hazan F; Ozturk A; Yararbas K; Tukun A
    Pediatr Neurol; 2014 Jun; 50(6):640-7. PubMed ID: 24742800
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lack of toxicity of alpha-sarcoglycan overexpression supports clinical gene transfer trial in LGMD2D.
    Rodino-Klapac LR; Lee JS; Mulligan RC; Clark KR; Mendell JR
    Neurology; 2008 Jul; 71(4):240-7. PubMed ID: 18525034
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel mutations in three patients with LGMD2C with phenotypic differences.
    Vermeer S; Verrips A; Willemsen MA; ter Laak HJ; Ginjaar IB; Hamel BC
    Pediatr Neurol; 2004 Apr; 30(4):291-4. PubMed ID: 15087111
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enrichment of the R77C alpha-sarcoglycan gene mutation in Finnish LGMD2D patients.
    Hackman P; Juvonen V; Sarparanta J; Penttinen M; Aärimaa T; Uusitalo M; Auranen M; Pihko H; Alén R; Junes M; Lönnqvist T; Kalimo H; Udd B
    Muscle Nerve; 2005 Feb; 31(2):199-204. PubMed ID: 15736300
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Beta-sarcoglycan gene mutations in Turkey.
    Balci B; Wilichowski E; Haliloğlu G; Talim B; Aurino S; Kremer E; Ebinger F; Senbil N; Anlar B; Kale G; Nigro V; Topaloğlu H; Bonnemann C; Dinçer P
    Acta Myol; 2004 Dec; 23(3):154-8. PubMed ID: 15938573
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alpha-sarcoglycan is recycled from the plasma membrane in the absence of sarcoglycan complex assembly.
    Draviam RA; Wang B; Shand SH; Xiao X; Watkins SC
    Traffic; 2006 Jul; 7(7):793-810. PubMed ID: 16787395
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Deficiency of the 50 kDa dystrophin-associated-glycoprotein (adhalin) in an Indian autosomal recessive limb girdle muscular dystrophy patient : immunochemical analysis and clinical aspects.
    Handa V; Mital A; Gupta M; Goyle S
    Neurol India; 2001 Mar; 49(1):19-24. PubMed ID: 11303236
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of the UK diagnostic strategy for limb girdle muscular dystrophy 2A.
    Groen EJ; Charlton R; Barresi R; Anderson LV; Eagle M; Hudson J; Koref MS; Straub V; Bushby KM
    Brain; 2007 Dec; 130(Pt 12):3237-49. PubMed ID: 18055493
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel mutation in alpha sarcoglycan gene in an Iranian family with limb girdle muscular dystrophy 2D.
    Mojbafan M; Nilipour Y; Tonekaboni SH; Tavakkoly-Bazzaz J; Zeinali S
    Neurol Res; 2016 Mar; 38(3):220-3. PubMed ID: 27093116
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Limb girdle muscular dystrophy: use of dHPLC and direct sequencing to detect sarcoglycan gene mutations in a New Zealand cohort.
    Love DR
    Clin Genet; 2004 Jan; 65(1):55-60. PubMed ID: 15032976
    [No Abstract]   [Full Text] [Related]  

  • 16. Sarcoglycanopathies are responsible for 68% of severe autosomal recessive limb-girdle muscular dystrophy in the Brazilian population.
    Vainzof M; Passos-Bueno MR; Pavanello RC; Marie SK; Oliveira AS; Zatz M
    J Neurol Sci; 1999 Mar; 164(1):44-9. PubMed ID: 10385046
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epsilon-sarcoglycan compensates for lack of alpha-sarcoglycan in a mouse model of limb-girdle muscular dystrophy.
    Imamura M; Mochizuki Y; Engvall E; Takeda S
    Hum Mol Genet; 2005 Mar; 14(6):775-83. PubMed ID: 15689353
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A phase I trial of adeno-associated virus serotype 1-γ-sarcoglycan gene therapy for limb girdle muscular dystrophy type 2C.
    Herson S; Hentati F; Rigolet A; Behin A; Romero NB; Leturcq F; Laforêt P; Maisonobe T; Amouri R; Haddad H; Audit M; Montus M; Masurier C; Gjata B; Georger C; Cheraï M; Carlier P; Hogrel JY; Herson A; Allenbach Y; Lemoine FM; Klatzmann D; Sweeney HL; Mulligan RC; Eymard B; Caizergues D; Voït T; Benveniste O
    Brain; 2012 Feb; 135(Pt 2):483-92. PubMed ID: 22240777
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Severe limb girdle muscular dystrophy in Spanish gypsies: further evidence for a founder mutation in the gamma-sarcoglycan gene.
    Lasa A; Piccolo F; de Diego C; Jeanpierre M; Colomer J; Rodríguez MJ; Urtizberea JA; Baiget M; Kaplan J; Gallano P
    Eur J Hum Genet; 1998; 6(4):396-9. PubMed ID: 9781048
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sarcoglycanopathies: a clinicopathological study of 13 cases [corrected].
    Sharma MC; Mannan R; Singh NG; Gulati S; Kalra V; Sarkar C
    Neurol India; 2004 Dec; 52(4):446-9. PubMed ID: 15626830
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.